https://www.selleckchem.com/pr....oducts/dihydroethidi
7%), OS rate was 94.6%. Both age groups had similar oncologic characteristics. There was a trend toward worse OS (2/11 and 1/45, = .06) but not for DFS (7/11 and 15/43, = .18) in patients 30years of age compared to 30-40years. There were no differences in OS (3/44 vs 0/88, = .44) or DFS (17/42 vs 3/8, = .8 between sporadic vs non-sporadic malignancies, respectively. Patients ≤40years of age with malignancy have advanced tumor stages and aggressive tumor characteristics at diagnosis. Although there is higher OS risk for pat
Like
Comment
Share